<DOC>
	<DOCNO>NCT01079091</DOCNO>
	<brief_summary>Patients compensate chronic liver disease episode acute deterioration liver function ( acute-on-chronic liver failure ) know 90 % mortality rate . Hepa Wash ( R ) newly develop liver renal support system base use recycle albumin dialysate . The new system show high detoxification capacity in-vitro preclinical study . The aim study evaluate safety efficacy Hepa Wash system patient acute-on-chronic liver failure intensive care unit .</brief_summary>
	<brief_title>Hepa Wash Treatment Patients With Acute-on-Chronic Liver Failure Intensive Care Units</brief_title>
	<detailed_description />
	<mesh_term>Liver Failure</mesh_term>
	<mesh_term>End Stage Liver Disease</mesh_term>
	<mesh_term>Acute-On-Chronic Liver Failure</mesh_term>
	<mesh_term>Liver Failure , Acute</mesh_term>
	<criteria>1 . Patients document clinical histological evidence cirrhosis AND 2 . Acute decompensation previously stable cirrhotic liver disease AND 3 . Bilirubin ≥ 2 mg/dl AND 4 . SOFA ≥ 9 calculate 12 hour optimal medical therapy AND 5 . Patient intensive care unit AND 6 . Informed consent patient legal representative AND 7 . Patients 18y old AND 8 . Enrollment patient within 96 hour fulfil inclusion criterion ( 15 ) 1 . Untreatable extrahepatic cholestasis 2 . Patient survival prognosis le 6 week chronic disease ( e.g . metastasize cancer ) acute event lead ICU admission . 3 . PaO2/FIO2 ≤ 100 mmHg ( respiratory SOFAscore 4 ) 4 . Patients receive vasopressor support Dopamine &gt; 15 µg/kg/min epinephrine &gt; 0.1 µg/kg/min norepinephrine &gt; 0.1 µg/kg/min ( cardiovascular SOFAscore 4 ) 5 . Patients creatinine ≥5 mg/dl urine output &lt; 200 ml/day ( renal SOFAscore 4 ) 6 . Patients kidney dialysis 7 . Patient MELDscore 40 8 . Mean arterial pressure ≤ 50 mmHg despite conventional medical treatment 9 . Patient testament excludes use lifeprolonging measure 10 . Postoperative patient whose liver failure relate liver surgery 11 . Uncontrolled seizures 12 . Active uncontrolled bleed 13 . Weight ≥ 120 kg 14 . Pregnancy 15 . Patient diagnose CreutzfeldtJakob disease 16 . Participation another clinical study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Liver failure</keyword>
	<keyword>Hepatic insufficiency</keyword>
	<keyword>Liver Cirrhosis</keyword>
	<keyword>Artificial liver</keyword>
	<keyword>Albumin dialysis</keyword>
</DOC>